What is Cosmos Holdings Inc.'s market cap?

Cosmos Holdings Inc. (COSM) has a market capitalization of $12.9M and trades on NASDAQ.

Who are Cosmos Holdings Inc.'s competitors?

Cosmos Holdings Inc.'s key competitors include Viatris, Sunshine Biopharma Inc., Amneal Pharmaceuticals, Inc. Class A Common Stock, and others. These companies compete in similar markets and product categories.

Who does Cosmos Holdings Inc. partner with?

Cosmos Holdings Inc.'s notable partners include Amazon, CloudPharm PC, National Hellenic Research Foundation, and others.

What subsidiaries does Cosmos Holdings Inc. have?

Cosmos Holdings Inc.'s subsidiaries include SkyPharm S.A., Cosmofarm S.A., Cana S.A., and others.

Where is Cosmos Holdings Inc. headquartered?

Cosmos Holdings Inc. is headquartered in United States of America and employs approximately 102 people. It has been publicly traded since 2010.

Cosmos Holdings Inc.

COSM

Cosmos Health Inc. is a vertically integrated global healthcare group that develops, manufactures, and distributes a diverse portfolio of proprietary pharmaceutical and nutraceutical brands.

Market cap

$12.88M-51.1%

Table of contents

Earnings

Q1 2026 report

May 21, 2026

Revenue$17.9MIn line EPS-$0.06In line

Read the full report

Next report

Aug 17, 2026 (In 2 weeks)

Revenue estimate$19.4M

EPS estimate$0.01

Competitors

By market cap

Cardinal Health$53.7B+44.0%

Viatris$20.5B+89.0%

Amneal Pharmaceuticals, Inc.$5.8B+126%

Organon$3.6B+37.2%

Opko Health$936.3M-12.5%

Cumberland Pharmaceuticals$105.3M+102%

Cosmos Holdings Inc.$12.9M-37.2%

Sunshine Biopharma$245.8K-96.5%

By revenue growth

Cardinal Health+12.8%

Amneal Pharmaceuticals, Inc.+7.6%

Cumberland Pharmaceuticals+2.1%

Viatris+1.6%

Organon-2.1%

Opko Health-11.5%

By net margin

Organon7.95%-5.0pp

Amneal Pharmaceuticals, Inc.4.01%+4.5pp

Cardinal Health0.62%-0.1pp

Viatris-2.04%+24.4pp

Opko Health-12.4%+14.3pp

Cumberland Pharmaceuticals-17.6%-9.6pp

Profile

Cosmos Health Inc. is a vertically integrated global healthcare group that develops, manufactures, and distributes a diverse portfolio of proprietary pharmaceutical and nutraceutical brands. The company leverages an AI-powered drug repurposing platform and a telehealth network to provide comprehensive healthcare solutions ranging from generic medicines to innovative oncology treatments. Its core value proposition lies in its lean, integrated operating model that spans from research and development to wholesale distribution and direct-to-consumer digital health services.

Competitive position

The company maintains a competitive edge through its vertically integrated model and AI-driven R&D, focusing on high-barrier-to-entry generic products and proprietary wellness brands.

GeographiesGreece, United Kingdom, European Union, United Arab Emirates, United States

Customer segmentsHealthcare providers, Wholesale distributors, Retail consumers, Government agencies

Business modelVertically integrated manufacturing, Wholesale distribution, Subscription SaaS, Direct-to-consumer e-commerce

SuppliersRaw material suppliers, Contract research organizations, Academic research institutions, Robotic warehouse technology providers

CustomersRetail pharmacy chains, Public and private hospitals, Pharmaceutical wholesalers, Direct-to-consumer e-commerce shoppers

CountryUnited States of America

Listed2010

Employees102.0

CEOGrigorios Siokas

SectorHealthcare

IndustryDrug Manufacturers - Specialty & Generic

Websitecosmoshold.com

FilingsSEC EDGAR

Questions, answered.

What is Cosmos Holdings Inc.'s market cap?: Cosmos Holdings Inc. (COSM) has a market capitalization of $12.9M and trades on NASDAQ.
Who are Cosmos Holdings Inc.'s competitors?: Cosmos Holdings Inc.'s key competitors include Viatris, Sunshine Biopharma Inc., Amneal Pharmaceuticals, Inc. Class A Common Stock, and others. These companies compete in similar markets and product categories.
Who does Cosmos Holdings Inc. partner with?: Cosmos Holdings Inc.'s notable partners include Amazon, CloudPharm PC, National Hellenic Research Foundation, and others.
What subsidiaries does Cosmos Holdings Inc. have?: Cosmos Holdings Inc.'s subsidiaries include SkyPharm S.A., Cosmofarm S.A., Cana S.A., and others.
Where is Cosmos Holdings Inc. headquartered?: Cosmos Holdings Inc. is headquartered in United States of America and employs approximately 102 people. It has been publicly traded since 2010.